180 related articles for article (PubMed ID: 31798347)
1. High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients.
Chen Y; Sun Y; Cui Y; Lei Y; Jiang N; Jiang W; Wang H; Chen L; Luo J; Chen Y; Tang K; Zhou C; Ke Z
Cancer Cell Int; 2019; 19():318. PubMed ID: 31798347
[TBL] [Abstract][Full Text] [Related]
2. CTHRC1 expression is a novel shared diagnostic and prognostic biomarker of survival in six different human cancer subtypes.
Sial N; Ahmad M; Hussain MS; Iqbal MJ; Hameed Y; Khan M; Abbas M; Asif R; Rehman JU; Atif M; Khan MR; Hameed Z; Saeed H; Tanveer R; Saeed S; Sharif A; Asif HM
Sci Rep; 2021 Oct; 11(1):19873. PubMed ID: 34615943
[TBL] [Abstract][Full Text] [Related]
3. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.
Niedergethmann M; Hildenbrand R; Wostbrock B; Hartel M; Sturm JW; Richter A; Post S
Pancreas; 2002 Aug; 25(2):122-9. PubMed ID: 12142733
[TBL] [Abstract][Full Text] [Related]
4. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
[TBL] [Abstract][Full Text] [Related]
5. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
6. CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma.
Meng C; Zhang Y; Jiang D; Wang J
World J Surg Oncol; 2022 Mar; 20(1):89. PubMed ID: 35307012
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of CTHRC1 predicts unfavorable prognosis in patients with pancreatic ductal adenocarcinoma.
Liu W; Fu XL; Yang JY; Yang MW; Tao LY; Liu DJ; Huo YM; Zhang JF; Hua R; Sun YW
Am J Cancer Res; 2016; 6(8):1820-7. PubMed ID: 27648368
[TBL] [Abstract][Full Text] [Related]
8. Activation of CTHRC1 by HOXB9 Promotes Angiogenesis through Fatty Acid Metabolism in Lung Adenocarcinoma.
Liu K; Li X; Yang Z; Zhang R
Rev Invest Clin; 2022; 75(2):63-75. PubMed ID: 37205792
[TBL] [Abstract][Full Text] [Related]
9. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
[TBL] [Abstract][Full Text] [Related]
10. [Effect of vascular endothelial growth factor C and collagen triple helix repeat containing 1 expression on prognosis of rectal carcinoma patients].
Yin WH; Fan HZ; Sheng JW; Xia HM; Wu YW; Xie P
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):673-5. PubMed ID: 23888454
[TBL] [Abstract][Full Text] [Related]
11. Collagen Triple Helix Repeat Containing 1 Expression in Osteosarcoma: A New Predictor of Prognosis.
Liu Y; Abulimiti N; Wang C
Ann Clin Lab Sci; 2018 May; 48(3):338-344. PubMed ID: 29970438
[TBL] [Abstract][Full Text] [Related]
12. CTHRC1 is associated with immune cell infiltration and functions as an adverse marker for prognosis in head and neck squamous cell carcinoma.
Zhong R; Yang M; Zhu R; Zhang J; Wang L
Oncol Lett; 2023 Apr; 25(4):133. PubMed ID: 36909370
[TBL] [Abstract][Full Text] [Related]
13. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
[TBL] [Abstract][Full Text] [Related]
14. Collagen triple helix repeat containing 1 (Cthrc1) is an independently prognostic biomarker of non-small cell lung cancers with cigarette smoke.
Liu X; Liu B; Cui Y; Wang F; Sun H; Lv F
Tumour Biol; 2014 Nov; 35(11):11677-83. PubMed ID: 25139095
[TBL] [Abstract][Full Text] [Related]
15. Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma.
Li N; Chen L; Liu C; Jiang Y; Rong J
Hum Pathol; 2019 Mar; 85():235-241. PubMed ID: 30381261
[TBL] [Abstract][Full Text] [Related]
16. CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma.
Zhou H; Su L; Liu C; Li B; Li H; Xie Y; Sun D
Onco Targets Ther; 2019; 12():7823-7831. PubMed ID: 31576140
[TBL] [Abstract][Full Text] [Related]
17.
Huang L; Yin Y; Qian D; Cao Y; Wang D; Wu X; Ming L; Huang Z; Zhou L
J Thorac Dis; 2023 Apr; 15(4):2022-2036. PubMed ID: 37197507
[TBL] [Abstract][Full Text] [Related]
18. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
Front Oncol; 2020; 10():570819. PubMed ID: 33628726
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.
Ke Z; He W; Lai Y; Guo X; Chen S; Li S; Wang Y; Wang L
Oncotarget; 2014 Oct; 5(19):9410-24. PubMed ID: 25238260
[TBL] [Abstract][Full Text] [Related]
20. Cthrc1 overexpression is an independent prognostic marker in gastric cancer.
Gu L; Liu L; Zhong L; Bai Y; Sui H; Wei X; Zhang W; Huang P; Gao D; Kong Y; Lou G
Hum Pathol; 2014 May; 45(5):1031-8. PubMed ID: 24746208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]